TP53 and cancer: Crucially, genetic changes in regulators of mitochondrial dynamics, like the downregulation of p53, which typically inhibits fission, and amplifications of DNM1L (Drp1), further entrench cancer cells in a state that is resistant to apoptosis and pro-metastatic.